Formulary apportionment is not used as a method of attributing profit between (rather than within) national tax jurisdictions [REF].
Several US states allow, but do not mandate, that a corporate group include foreign entities for the purpose of assessing factors used in formulary apportionment ("worldwide unitary combination").